| Literature DB >> 31849207 |
Daria Kuznetsova1, Svetlana Rodimova1, Alexander Gulin2,3, Dmitry Reunov1, Nikolai Bobrov1,4, Anastasia Polozova1, Alexander Vasin2,3, Vladislav Shcheslavskiy1,5, Natalia Vdovina1, Vladimir Zagainov1,4, Elena Zagaynova1.
Abstract
Conventional techniques are insufficient precisely to describe the internal structure, the heterogeneous cell populations, and the dynamics of biological processes occurring in diseased liver during surgery. There is a need for a rapid and safe method for the successful diagnosis of liver disease in order to plan surgery and to help avoid postoperative liver failure. We analyze the progression of both acute (cholestasis) and chronic (fibrosis) liver pathology using multiphoton microscopy with fluorescence lifetime imaging and second-harmonic generation modes combined with time-of-flight secondary ion mass spectrometry chemical analysis to obtain new data about pathological changes to hepatocytes at the cellular and molecular levels. All of these techniques allow the study of cellular metabolism, lipid composition, and collagen structure without staining the biological materials or the incorporation of fluorescent or other markers, enabling the use of these methods in a clinical situation. The combination of multiphoton microscopy and mass spectrometry provides more complete information about the liver structure and function than could be assessed using either method individually. The data can be used both to obtain new criteria for the identification of hepatic pathology and to develop a rapid technique for liver quality analysis in order to plan surgery and to help avoid postoperative liver failure in clinic.Entities:
Keywords: fluorescence lifetime imaging; liver; metabolic imaging; multiphoton microscopy; time-of-flight secondary ion mass spectrometry
Mesh:
Year: 2019 PMID: 31849207 PMCID: PMC7008498 DOI: 10.1117/1.JBO.25.1.014508
Source DB: PubMed Journal: J Biomed Opt ISSN: 1083-3668 Impact factor: 3.170
Fig. 1Specific changes in acute cholestasis after 1 week and with chronic fibrosis after 12 weeks. Fluorescence intensity images with morphological data. NAD(P)H: excitation 750 nm, detection 455 to 500 nm; FAD/bilirubin: excitation 900 nm, detection 500 to 550 nm; AF (red): excitation 800 nm, detection 433 to 660 nm; SHG (green): excitation 800 nm, detection 371 to 421 nm. VG: Van Gieson picrofuchsin. Bar: .
TPEF intensity for normal and diseased livers.
| (a) Acute cholestasis | |||||
|---|---|---|---|---|---|
| Intensity (a.u.) | Excitation 750 nm [NAD(P)H] | Intensity (a.u.) | Excitation 900 nm (FAD/bilirubin) | ||
| Area 1 | Area 2 | Area 1 | Area 2 | ||
| Control | Control | ||||
| 1 week | 1 week | ||||
| 3 weeks | 3 weeks | ||||
| (b) Chronic fibrosis | |||||
| Intensity (a.u.) | Excitation 750 nm [NAD(P)H] | Intensity (a.u.) | Excitation 900 nm (FAD) | ||
| Area 1 | Area 2 | Area 1 | Area 2 | ||
| Control | Control | ||||
| 4 weeks | 4 weeks | ||||
| 8 weeks | 8 weeks | ||||
| 12 weeks | 12 weeks | ||||
Statistically significant difference from control, .
Statistically significant difference from area 1, .
Fig. 2TPEF intensity of NAD(P)H for normal and diseased livers.
Fig. 3FLIM images of NAD(P)H in liver tissue in acute cholestasis after 1 week and chronic fibrosis after 12 weeks. Amplitude weighted mean lifetime () and the relative contributions of protein-free and protein-bound NAD(P)H for the tri-exponential fitting model. Bar .
Fluorescence lifetimes and the relative contributions of different forms of NAD(P)H and FAD [, and for the NAD(P)H tri-exponential fitting model, and for the FAD bi-exponential fitting model] in normal and diseased livers.
| (a) Acute cholestasis | ||||||||||
| NAD(P)H, tri-exponential fitting model | ||||||||||
| Area 1 | Area 2 | Area 1 | Area 2 | Area 1 | Area 2 | Area 1 | Area 2 | Area 1 | Area 2 | |
| Control | ||||||||||
| 1 week | ||||||||||
| 3 weeks | ||||||||||
| (b) Chronic fibrosis | ||||||||||
| NAD(P)H, tri-exponential fitting model | ||||||||||
| | ||||||||||
| Area 1 | Area 2 | Area 1 | Area 2 | Area 1 | Area 2 | Area 1 | Area 2 | Area 1 | Area 2 | |
| Control | ||||||||||
| 4 weeks | ||||||||||
| 8 weeks | ||||||||||
| 12 weeks | ||||||||||
| (c) Chronic fibrosis | ||||||||||
| FAD, two-exponential fitting model | ||||||||||
| | ||||||||||
| | Area 1 | Area 2 | Area 1 | Area 2 | Area 1 | Area 2 | Area 1 | Area 2 | Area 1 | Area 2 |
| Control | ||||||||||
| 4 weeks | ||||||||||
| 8 weeks | ||||||||||
| 12 weeks | ||||||||||
Statistically significant difference from area 1, .
Statistically significant difference from control, .
Fig. 4TOF-SIMS analysis of liver tissues for acute cholestasis after 3 weeks and for chronic fibrosis after 12 weeks. Ion yields were normalized to the control sample. (a) Glycine ( 30), proline ( 68 and 70), arginine ( 73), phosphatidylcholine ( 184), and cholesterol ( 369). (b) Ratio of unsaturated/saturated fatty acids.